Top Stories

Abbott and St. Jude Attempt To Thread The Needle

By Joseph Mullings The Abbott/St. Jude merger is going to be interesting to watch.  Both companies have been in need of “finding growth” for the top line.  The product development pipeline for meaningful technology in both companies has been pretty meager. St. Jude is already in the midst of integrating Thoratec and still struggling with the integration of smaller properties like Cardiomems. Integrating these types of technologies requires a high touch of clinical expertise, not [...]

“Once the Candidate Appears” is Different than “Making the Candidate Appear”

By Joseph Mullings Our firm works with a number of different types of companies in the med-tech market. They include emerging technology companies, large multi-nationals and mid-cap companies. Over the years I have shared with my clients that we do an incredibly effective job of managing the hiring process. Ultimately that is what they pay us for. As the market becomes more sophisticated, the hiring process has become a bit more blurred. Not by us, [...]

Going From Project Engineer To President

By Joseph Mullings Recently, I placed a President into a multi-billion dollar per year, multi-national client.  He is heading up one of their divisions in the Greater Philadelphia area.  As usual, I really enjoy putting the deal together for my clients and especially for the candidates I work with.  It is never lost on me that it is life changing for the people that my firm places.  As we put the final touches on the [...]

International News

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ --Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its [...]

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million. The agreement (signed today) calls for an upfront payment of $90 million payable [...]

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks * Changes follow French breast implant safety scandal * Plans must be approved by EU governments, lawmakers BRUSSELS, Sept 26 (Reuters) - The European Union has proposed tougher rules on assessing the safety and monitoring the use of [...]

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately. "Surefire Medical developed this ground-breaking technology to provide interventional [...]